Michael Quinn
Independent Chairman
Innate Immunotherapeutics
New Zealand
Biography
As an executive and director Michael has participated in ASX, AIM, NASDAQ and NYSE initial public offerings for life science, electronics and engineering businesses. He has extensive M&A and capital raising experience. After an early career in banking, transport and radiation cross linked plastics in Australia, London and Silicon valley he co-founded Memtec in 1982. Memtec revolutionised filtration in the water and waste water industries and developed large manufacturing and sales operations in Australia, USA, Europe and Asia until it was acquired by US Filter in 1997. In 2013 Michael retired as a director of ResMed Inc (ASX and NYSE: RMD), after 21 years. In 1999 he co-founded Innovation Capital which currently owns substantial holdings in high technology business engaged in alternative energy, medical devices, diagnostics and advanced audio systems.
Research Interest
Research Interest ON immunology
